Mr Andrew Cameron
- Honorary Clinical Lecturer (School of Cancer Sciences)
email:
Andrew.Cameron@glasgow.ac.uk
Wolfson Wohl Cancer Research Centre, Garscube Estate, G61 1BD
https://orcid.org/0000-0002-7065-9033Research interests
Research groups
- Pancreatic
Publications
2024
McGuigan, M.-C., Hadjicosti, R., Cameron, A. J. , Coats, M., Chang, D. , Dickson, E. J., Holroyd, D., McKay, C. J. and Jamieson, N. B. (2024) The surveillance strategy for Intraductal Pancreatic Mucinous Neoplasms: Criteria for discontinuation. Annals of Surgery, (doi: 10.1097/SLA.0000000000006580) (PMID:39480643) (Accepted for Publication)
Lucocq, J. et al. (2024) Precursor epithelial subtypes of adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN): clinicopathological features, recurrence and response to adjuvant chemotherapy. Annals of Surgical Oncology, 31(10), pp. 7023-7032. (doi: 10.1245/s10434-024-15677-z) (PMID:38961040)
Stankey, C.T. et al. (2024) A disease-associated gene desert directs macrophage inflammation through ETS2. Nature, 630(8016), pp. 447-456. (doi: 10.1038/s41586-024-07501-1) (PMID:38839969)
Robertson, F. P., Cameron, A. , Spiers, H. V.M., Joseph, N., Taylor, E., Ratnayake, B., Jamieson, N. B. and Pandanaboyana, S. (2024) Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: A systematic review. HPB, 26(5), pp. 609-617. (doi: 10.1016/j.hpb.2024.02.001) (PMID:38401998)
Lucocq, J. et al. (2024) Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study. British Journal of Surgery, 111(4), znae100. (doi: 10.1093/bjs/znae100) (PMID:38659247)
Lucocq, J. et al. (2024) Long-term outcomes following resection of Adenocarcinoma arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): a propensity-score matched analysis. Annals of Surgery, (doi: 10.1097/SLA.0000000000006272) (PMID:38516777) (Early Online Publication)
2023
Lucocq, J. et al. (2023) Risk of recurrence after surgical resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia (IPMN) with patterns of distribution and treatment. Annals of Surgery, 280(1), pp. 126-135. (doi: 10.1097/sla.0000000000006144) (PMID:37873663)
Wood, C. S. et al. (2023) Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases. Cancer Research, 83(8), pp. 1329-1344. (doi: 10.1158/0008-5472.CAN-22-2794) (PMID:37057593) (PMCID:PMC10102851)
2022
Fisher, N. C. et al. (2022) Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data. Clinical Cancer Research, 28(18), pp. 4056-4069. (doi: 10.1158/1078-0432.CCR-22-1102) (PMID:35792866) (PMCID:PMC9475248)
Articles
McGuigan, M.-C., Hadjicosti, R., Cameron, A. J. , Coats, M., Chang, D. , Dickson, E. J., Holroyd, D., McKay, C. J. and Jamieson, N. B. (2024) The surveillance strategy for Intraductal Pancreatic Mucinous Neoplasms: Criteria for discontinuation. Annals of Surgery, (doi: 10.1097/SLA.0000000000006580) (PMID:39480643) (Accepted for Publication)
Lucocq, J. et al. (2024) Precursor epithelial subtypes of adenocarcinoma arising from intraductal papillary mucinous neoplasms (A-IPMN): clinicopathological features, recurrence and response to adjuvant chemotherapy. Annals of Surgical Oncology, 31(10), pp. 7023-7032. (doi: 10.1245/s10434-024-15677-z) (PMID:38961040)
Stankey, C.T. et al. (2024) A disease-associated gene desert directs macrophage inflammation through ETS2. Nature, 630(8016), pp. 447-456. (doi: 10.1038/s41586-024-07501-1) (PMID:38839969)
Robertson, F. P., Cameron, A. , Spiers, H. V.M., Joseph, N., Taylor, E., Ratnayake, B., Jamieson, N. B. and Pandanaboyana, S. (2024) Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: A systematic review. HPB, 26(5), pp. 609-617. (doi: 10.1016/j.hpb.2024.02.001) (PMID:38401998)
Lucocq, J. et al. (2024) Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study. British Journal of Surgery, 111(4), znae100. (doi: 10.1093/bjs/znae100) (PMID:38659247)
Lucocq, J. et al. (2024) Long-term outcomes following resection of Adenocarcinoma arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): a propensity-score matched analysis. Annals of Surgery, (doi: 10.1097/SLA.0000000000006272) (PMID:38516777) (Early Online Publication)
Lucocq, J. et al. (2023) Risk of recurrence after surgical resection for adenocarcinoma arising from intraductal papillary mucinous neoplasia (IPMN) with patterns of distribution and treatment. Annals of Surgery, 280(1), pp. 126-135. (doi: 10.1097/sla.0000000000006144) (PMID:37873663)
Wood, C. S. et al. (2023) Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases. Cancer Research, 83(8), pp. 1329-1344. (doi: 10.1158/0008-5472.CAN-22-2794) (PMID:37057593) (PMCID:PMC10102851)
Fisher, N. C. et al. (2022) Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data. Clinical Cancer Research, 28(18), pp. 4056-4069. (doi: 10.1158/1078-0432.CCR-22-1102) (PMID:35792866) (PMCID:PMC9475248)
Grants
Grants and Awards listed are those received whilst working with the University of Glasgow.
- Early Detection of Pancreatic Cancer
NHS Greater Glasgow and Clyde Endowment Funds
2023 - 2025
- Spatial Gene Expression of Pancreatic Intraductal Papillary Mucinous Neoplasms
Royal College of Surgeons of Edinburgh
2022 - 2023
- Multi-Modal analysis of composition and spatial architecture in human premalignant pancreatic lesions to enhance early detection and chemoprevention strategies.
NHS Greater Glasgow and Clyde Endowment Funds
2021 - 2023